Feed intake, rectal temperature, and serum mineral concentrations of feedlot cattle fed zinc oxide or zinc methionine and challenged with infectious bovine rhinotracheitis virus.
Three experiments were conducted using feedlot steers in a randomized block design to determine the effect of zinc methionine (ZnMet) and zinc oxide (Exp. 3) on feed intake (DMI), rectal temperature, and serum mineral concentrations of feedlot cattle challenged with infectious bovine rhinotracheitis virus (IBRV). All the steers used were seronegative to IBRV. Steers were adapted for 7 d to their respective diets and challenged with 3.7 x 10(5) plaque forming units of IRBV on d 0 of each experiment. Live BW, rectal temperature, and individual daily DMI were recorded for 14 d. Blood samples were taken on d 0, 7, and 14. In Exp. 1, daily DMI of the control steers (Zn = 31 ppm) decreased 50% compared with 15% in the ZnMet (Zn = 90 ppm) steers 3 d after IBRV challenge. By d 6, the ZnMet steers had regained their pretrial mean daily DMI, but the control steers took 11 d. The ZnMet steers had lower (P less than .05) mean rectal temperature than the control steers on d 7 and 12. In Exp. 2, the control (Zn = 35 ppm) steers had lower (P less than .05) daily DMI on d 8 to 12 than the ZnMet (Zn = 89 ppm) steers. In Exp. 3, the mean decrease in daily DMI tended to be more rapid in the ZnO steers than in the control and ZnMet steers. All steers had the lowest daily DMI on d 5 and 6, coinciding with the highest rectal temperature. Serum Zn, P, and Mg concentrations decreased and serum Cu increased in all steers after infection. These data suggest that dietary Zn enhanced the recovery rate of IBRV-stressed cattle.
Chirase
N K
NK
Texas Agricultural Experiment Station, Amarillo 79109.
Hutcheson
D P
DP
Thompson
G B
GB
D000818:Animals; D001831:Body Temperature / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D002417:Cattle; D004435:Eating / Q000187:drug effects*; D007241:Infectious Bovine Rhinotracheitis / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008715:Methionine / Q000494:pharmacology / Q000627:therapeutic use; D008903:Minerals / Q000097:blood*; D011897:Random Allocation; D015032:Zinc / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D015034:Zinc Oxide / Q000494:pharmacology / Q000627:therapeutic use
D008903:Minerals; D008715:Methionine; D015032:Zinc; D015034:Zinc Oxide